Project Grant HT94252410021
Award Date
2/1/24
Completion Date
1/31/26
Dollars Obligated
$311K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The University of Washington was awarded a $1,810,550 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 through September 30, 2026 to investigate early chemodenervation of the detrusor muscle to preserve bladder compliance and function over the long term following spinal cord injury. The Military Medical Research and Development program supports basic,...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $5,465,906 Project Grant to the University of Maryland, Baltimore to conduct the "TELE-SLEEP OSA" study. This 4-year research project aims to evaluate the clinical effectiveness, implementation, and economic impact of telehealth care for obstructive sleep apnea within the Military Health System. The University of Maryland, Baltimore has issued a $1,892,006 sub-grant to...
The University of Washington was awarded a $1,137,371 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from January 2021 through January 2025 to rapidly test a novel therapeutic strategy for COVID-19 using human organoids and blood vessel structures. The Military Medical Research and Development program aims to transform health care for service members and the public...
The University of Wisconsin System was awarded a $1,712,026 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE", will fund research at the University of Wisconsin - Madison campus between June 1, 2024 and May 31, 2028. The research aims to investigate a novel approach to addressing cognitive fatigue in military personnel. As a...
The U.S. Defense Health Agency awarded a $1,927,410.00 Project Grant to the University of Washington for the "CONTRAST-ENHANCED ULTRASOUND BIOMARKER FOR PROGNOSTICATION AND GUIDANCE OF SURGICAL TREATMENT IN ACUTE TRAUMATIC SPINAL CORD INJURY" project. The grant was awarded on August 31, 2023 and is scheduled for completion on August 30, 2026. This project falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced...
The University of Washington received a $617,221 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funds research to advance the efficacy, longevity, and safety of gene editing therapies for Duchenne muscular dystrophy (DMD). The 2-year grant period runs from August 15, 2023 to August 14, 2025. As a leading research institution, the University of Washington has previously received federal funding to support a...
The University of Washington was awarded a $2.2 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from January 2021 through January 2025 to rapidly test a novel therapeutic strategy for COVID-19 using human organoids and blood vessel structures. Through this funding, the University of Washington will investigate medical solutions for COVID-19 using...
The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
The University of Washington will receive $749,915 from the Defense Health Agency through September 2023 to August 2027 under the Military Medical Research and Development federal grant program (CFDA 12.420). The funding will support the university's project to enhance the efficacy of androgen receptor antagonist therapy with tumor necrosis factor-alpha blockade in metastatic prostate cancer. The Military Medical Research and Development program aims to transform military and public health...
The University of Arizona was awarded a $3,069,903 Project Grant by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, effective September 1, 2024 through August 31, 2027, will fund research on the "Effectiveness of Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep." This advanced biomedical research project aims to transform healthcare for military service...